RT Journal Article
ID 080d5ac50c883192
A1 Wu, Joseph M.
A1 Doonan, Barbara B.
A1 Hsieh, Tze-chen
A1 Yang, Qingyao
A1 Yang, Xiao-Tong
A1 Ling, Ming-Tat
T1 Recent Advances and Challenges in Studies of Control of Cancer Stem Cells and the Gut Microbiome by the Trametes-Derived Polysaccharopeptide PSP (Review)
JF International Journal of Medicinal Mushrooms
JO IJM
YR 2016
FD 2016-10-19
VO 18
IS 8
SP 651
OP 660
K1 cancer stem cells
K1 medicinal mushrooms
K1 PSP
K1 TCM
K1 Trametes versicolor
AB The medicinal mushroom Trametes versicolor has been well recognized for its activity in maintaining the general health of the population and in managing and treating human diseases in various cultures. Its use has been recently gaining acceptance and popularity in Western countries. The reported health benefits of T. versicolor led to a search for the identity of its bioactive ingredients. These efforts have resulted in the isolation of the polysaccharopeptide PSP from cultured mycelia of strain Cov-1, which expresses large amounts of PSP. The availability of highly purified PSP was followed by studies of its biological activities using tissue culture models and limited human clinical trials. In this review we summarize recent advances in the antitumorigenic and immunomodulatory effects of PSP, elimination of prostate cancer stem cells and control of the intestinal microbiome, and its interplay with host cells as a prebiotic. These findings may have implications for widening and repurposing the use of PSP
PB Begell House
LK https://www.dl.begellhouse.com/journals/708ae68d64b17c52,34f197783d902eab,080d5ac50c883192.html